Clinical Trial: Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838506) titled 'Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).' on Sept. 18.

Brief Summary: This study is testing a new investigational study drug called Urcosimod Ophthalmic Solution for the treatment of Neuropathic Corneal Pain (NCP).

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Neuropathic Corneal Pain

Intervention: DRUG: Urcosimod ophthalmic solution is a preservative-free topical ophthalmic product; supplied in unit dose ampoules; administered QID for 12-weeks.

Vehicl...